Michael Powell, Director at Orexigen Therapeutics, Inc. (OREX), sold 10,100 shares at $12.00 ($121K) on 2008-08-25, disclosed to the SEC on 2008-08-25.
Open-market sale of $121k OREX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 100 | $1K | 1.0% |
| 2 | $12.00 | 800 | $10K | 7.9% |
| 3 | $12.00 | 4,400 | $53K | 43.6% |
| 4 | $12.00 | 100 | $1K | 1.0% |
| 5 | $12.00 | 800 | $10K | 7.9% |
| 6 | $12.00 | 3,900 |
| $47K |
| 38.6% |
| Total | $12.00 avg | 10,100 | $121K | 100% |
| Filing → |
| OCRX | SELL | 2016-12-30 | $15K | — | Filing → |
| MIRN | BUY | 2015-10-06 | $6.0M | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |